UNITED THERAPEUTICS CORP (UTHR) Stock Analyst Ratings
USA - NASDAQ:UTHR - US91307C1027 - Common Stock
448.91 USD
-5.09 (-1.12%)
448.91 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 81% to UTHR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 499.6. This target is 11.29% above the current price.
UTHR was analyzed by 22 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about UTHR.
In the previous month the buy percentage consensus was at a similar level.
UTHR was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-06 | UBS | Maintains | Buy -> Buy |
| 2025-10-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-30 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-10 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-09-29 | UBS | Maintains | Buy -> Buy |
| 2025-09-26 | RBC Capital | Initiate | Outperform |
| 2025-09-10 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-09-05 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-09-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-04 | UBS | Maintains | Buy -> Buy |
| 2025-09-03 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-09-02 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-09-02 | Jefferies | Maintains | Buy -> Buy |
| 2025-08-13 | UBS | Maintains | Buy -> Buy |
| 2025-07-31 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-31 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-07-10 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-08 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-06-30 | UBS | Maintains | Buy -> Buy |
| 2025-06-11 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-06-02 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-05-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-01 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-01 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-25 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-04-21 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-04-21 | B of A Securities | Upgrade | Underperform -> Neutral |
| 2025-02-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-08 | UBS | Maintains | Buy -> Buy |
UNITED THERAPEUTICS CORP / UTHR FAQ
What is the price target for UTHR stock?
22 analysts have analysed UTHR and the average price target is 499.6 USD. This implies a price increase of 11.29% is expected in the next year compared to the current price of 448.91.
Can you provide the consensus rating for UNITED THERAPEUTICS CORP stock?
The consensus rating for UNITED THERAPEUTICS CORP (UTHR) is 80.9091 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover UNITED THERAPEUTICS CORP (UTHR) stock?
The number of analysts covering UNITED THERAPEUTICS CORP (UTHR) is 22.